Sitemap > Breaking Research > GenitoUrinary Tract Disorders
Displaying 451 - 500 of 759 results
- The effect of oxybutynin on structural changes of the obstructed guinea pig bladder.
- Beneficial effects of suplatast tosilate (IPD-1151T) in a rat cystitis model induced by intravesical hydrochloric acid.
- Effects of alfuzosin 10 mg once daily on sexual function in men treated for symptomatic benign prostatic hyperplasia.
- Functional and morphological improvement in erectile tissue of hypertensive rats by long-term combined therapy with phosphodiesterase type 5 inhibitor and losartan.
- Efficacy of vardenafil for the treatment of erectile dysfunction in men with hypertension: a meta-analysis of clinical trial data.
- Pharmacokinetics of doxazosin gastrointestinal therapeutic system after multiple administration in korean healthy volunteers.
- Efficacy and impact of botulinum toxin A on quality of life in patients with neurogenic detrusor overactivity.
- The effect of sildenafil citrate and pentoxifylline combined treatment in the management of erectile dysfunction.
- Efficacy of metformin in obese and non-obese women with polycystic ovary syndrome: a randomized, double-blinded, placebo-controlled cross-over trial.
- Botulinum Toxin A Detrusor Injections in Patients with Neurogenic Detrusor Overactivity Significantly Decrease the Incidence of Symptomatic Urinary Tract Infections.
- Discovery and structure-activity relationships of new steroidal compounds bearing a carboxy-terminal side chain as androgen receptor pure antagonists.
- A randomized double-blind placebo-controlled multicentre study to explore the efficacy and safety of tamsulosin and tolterodine in women with overactive bladder syndrome.
- Patterns of switching phosphodiesterase type 5 inhibitors in the treatment of erectile dysfunction: results from the Erectile Dysfunction Observational Study.
- Anandamide improves the impaired nitric oxide-mediated neurogenic relaxation of the corpus cavernosum in diabetic rats: involvement of cannabinoid CB(1) and vanilloid VR(1) receptors.
- Effect of letrozole on urinary bladder function in the female rabbit.
- Short-term efficacy and long-term compliance/treatment failure of the alpha1 blocker naftopidil for patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.
- Changes of gap junctional cell-cell communication in overactive detrusor in the rats.
- The Effect of Doxazosin, Finasteride and Combination Therapy on Nocturia in Men With Benign Prostatic Hyperplasia.
- Vardenafil Improves Urodynamic Parameters in Men With Spinal Cord Injury: Results From a Single Dose, Pilot Study.
- Effect of Recombinant Human Keratinocyte Growth Factor (rHuKGF, Palifermin) on Radiation-Induced Mouse Urinary Bladder Dysfunction.
- Aldose Reductase Inhibitor ONO-2235 Restores the Alterations of Bladder Nerve Growth Factor and Neurotrophin Receptor p75 Genetic Expression in Streptozotocin Induced Diabetic Rats.
- Safety and efficacy of escitalopram in the treatment of premature ejaculation: a double-blind, placebo-controlled, fixed-dose, randomized study.
- Effects of phosphodiesterase type 5 inhibitor on the contractility of prostate tissues and urethral pressure responses in a rat model of benign prostate hyperplasia.
- The prevalence and clinical relevance of sexual dysfunction in women and men with chronic heart failure.
- Is the metabolic syndrome a risk factor for female sexual dysfunction in sexually active women?
- Improvement of vascular function by acute and chronic treatment with the PDE-5 inhibitor sildenafil in experimental diabetes mellitus.
- Long-term darifenacin treatment for overactive bladder in patients aged 65 years and older: analysis of results from a 2-year, open-label extension study.
- Effects of antimuscarinics on voiding function after cerebral infarction in a rat model of overactive bladder.
- Aminocyclohexylsulfonamides: Discovery of metabolically stable alpha(1a/1d)-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS).
- Safety and efficacy of tolterodine extended release in men with overactive bladder symptoms and presumed non-obstructive benign prostatic hyperplasia.
- Potent oxindole based human beta(3) adrenergic receptor agonists.
- Evidence for the efficacy of duloxetine in treating mild, moderate, and severe depression.
- Naftopidil, a selective alpha-1 adrenoceptor antagonist, inhibits growth of human prostate cancer cells by G1 cell cycle arrest.
- Infusions of 3alpha,5alpha-THP to the VTA enhance exploratory, anti-anxiety, social, and sexual behavior and increase levels of 3alpha,5alpha-THP in midbrain, hippocampus, diencephalon, and cortex of female rats.
- Patient perceptions of the risks and benefits of infliximab for the treatment of inflammatory bowel disease.
- Efficacy, Safety and Tolerability of Fesoterodine for Overactive Bladder Syndrome.
- Does Tolterodine Extended Release Affect the Bladder Electrical Perception Threshold? A Placebo Controlled, Double-Blind Study With 4 and 8 mg in Healthy Volunteers.
- Danazol for pelvic pain associated with endometriosis.
- Effects of the Selective Prostacyclin Receptor Antagonist RO3244019 on the Micturition Reflex in Rats.
- An Evaluation of Semen Characteristics in Men 45 Years of Age or Older after Daily Dosing with Tadalafil 20mg: Results of a Multicenter, Randomized, Double-Blind, Placebo-Controlled, 9-Month Study.
- Deletion of the transient receptor potential cation channel TRPV4 impairs murine bladder voiding.
- Premature Ejaculation: Results from a Five-Country European Observational Study.
- Stereoselective synthesis of a novel 2-aza-7-oxabicyclo[3.3.0]octane as neurokinin-1 receptor antagonist.
- Treatment preferences in men with erectile dysfunction: an open label study in Korean men switching from sildenafil citrate to tadalafil.
- Acute Effects of Nicotine on Physiological and Subjective Sexual Arousal in Nonsmoking Men: A Randomized, Double-Blind, Placebo-Controlled Trial.
- Structure-Activity Studies of Novel Cyanoguanidine ATP-Sensitive Potassium Channel Openers for the Treatment of Overactive Bladder.
- Structural analogue of sildenafil identified as a novel corrector of the F508del-CFTR trafficking defect.
- Androgen receptor and 5alpha-reductase are expressed in pelvic endometriosis.
- Effects of oxybutynin transdermal system on health-related quality of life and safety in men with overactive bladder and prostate conditions.
- Metformin improves polycystic ovary syndrome symptoms irrespective of pre-treatment insulin resistance.